CRISPR Therapeutics’ (CRSP) Casebia Therapeutics JV Enters Collaboration Agreement with StrideBio – StreetInsider.com
|
CRISPR Therapeutics' (CRSP) Casebia Therapeutics JV Enters Collaboration Agreement with StrideBio
StreetInsider.com CRISPR Therapeutics (NASDAQ: CRSP) and Casebia Therapeutics, a joint-venture established by CRISPR Therapeutics and Bayer AG for developing CRISPR-based therapeutics in select disease areas, today announced they have signed a collaboration … |
